ID   OCI-C2p
AC   CVCL_DH03
DR   cancercelllines; CVCL_DH03
DR   GEO; GSM1001415
DR   GEO; GSM1001452
DR   GEO; GSM1001462
DR   Progenetix; CVCL_DH03
DR   Wikidata; Q54931749
RX   PubMed=26080861;
CC   Sequence variation: Mutation; HGNC; HGNC:8975; PIK3CA; Simple; p.Cys420Arg (c.1258T>C); ClinVar=VCV000031945; Zygosity=Unspecified (PubMed=26080861).
CC   Omics: SNP array analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
ST   Source(s): PubMed=26080861
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D13S317: 11,12
ST   D16S539: 8,13
ST   D5S818: 10,12
ST   D7S820: 9,11
ST   TH01: 7,9
ST   TPOX: 8,11
ST   vWA: 17,18
DI   NCIt; C40078; Ovarian clear cell adenocarcinoma
DI   ORDO; Orphanet_398971; Clear cell adenocarcinoma of the ovary
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 13-07-16; Last updated: 19-12-24; Version: 11
//
RX   PubMed=26080861; DOI=10.1038/ncomms8419; PMCID=PMC4473807;
RA   Ince T.A., Sousa A.D., Jones M.A., Harrell J.C., Agoston E.S.,
RA   Krohn M., Selfors L.M., Liu W.-B., Chen K., Yong M., Buchwald P.,
RA   Wang B., Hale K.S., Cohick E., Sergent P., Witt A., Kozhekbaeva Z.M.,
RA   Gao S.-Z., Agoston A.T., Merritt M.A., Foster R., Rueda B.R., Crum C.P.,
RA   Brugge J.S., Mills G.B.;
RT   "Characterization of twenty-five ovarian tumour cell lines that
RT   phenocopy primary tumours.";
RL   Nat. Commun. 6:7419.1-7419.14(2015).
//